Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Total payments for the HIV prevention pill exceeded $2 billion in 2018.
HIV efforts in Georgia and Texas could be seriously hindered—but those in Mississippi could be helped.
A new CDC study leaves the question of indoor versus outdoor dining unanswered.
Researchers are surprised and concerned that a strain of HIV that is so broadly resistant to treatment even has the capacity to transmit.
Staff at San Francisco AIDS Foundation found that many skills, such as delivering HIV test results, translated well.
A revamped National Harm Reduction Coalition tackles the “racist war on drugs” and advocates for people who use drugs.
This finding calls into question research that has projected that frequent testing among men on PrEP could drive down STI rates.
The D-peptide HIV entry inhibitor CPT31 is being developed with hopes it could be injected quarterly for both treatment and prevention.
A digital dashboard displays six gauges in the nation’s effort to lower HIV rates by 90% by 2030.
Here’s how the nation’s capital remains on track despite COVID-19.
A study found that men who started PrEP a week before a vacation and stopped a week after coming home adhered well to the daily regimen.
New mRNA vaccine approach protects monkeys from HIV-like virus.
A study in Chicago, where there has been a considerable effort to educate women about PrEP, found a low level of awareness.
A similar training program, ESCALATE, will teach communities to recognize and fight HIV stigma.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.